DRTS

DRTS

Alpha Tau Medical Ltd

Rev โ€”top 1%5Y
Hold

Alpha Tau Medical Ltd develops and commercializes diffusing alpha-emitters radiation therapy (Alpha DaRT) for treating solid tumors, including skin, pancreatic, prostate, lung, liver, and breast cancers, currently in clinical trials.

โš•๏ธ Healthcare NASDAQ Listed 2021 $ USD
$1,000 invested 5 years ago โ†’$1,412today

Score Overview

1 Year
Scoreโ€”
Net Growth-33.42%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Scoreโ€”
Net Growth-108.55%
Net Trend20%
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendNever
Revenue Consistencyโ€”
All Time
Scoreโ€”
Net Growth-108.55%
Net Trend20%
Net Income Consistency
Rev Growthโ€”
Rev TrendNever
Revenue Consistency

See the full market ranking โ†’

Alpha Tau Medical Ltd fundamental performance

Across Alpha Tau Medical Ltd's full reported history, from 2021 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 27M to -$ 42M. Revenue increased in 0% of the years measured; net income in 20%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 13.87โ€”
1 Year2025-08-12
$ 3.25326.77%
5 Years2021-08-12
$ 9.8241.24%
All Time2021-03-08
$ 10.1037.33%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 0.00-$ 56M$ 80M
2025$ 0.00-$ 42M$ 76M
2024$ 0.00-$ 31M$ 59M
2023$ 0.00-$ 29M$ 81M
2022$ 0.00-$ 33M$ 104M
IPO2021$ 0.00-$ 27M$ 31M

Explore beyond DRTS

You're looking at Alpha Tau Medical Ltd. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies